LpxH-IN-AZ1 is primarily utilized in the field of microbiology and pharmaceutical research as a potent inhibitor targeting the LpxH enzyme. This enzyme plays a critical role in the biosynthesis of lipid A, a key component of the outer membrane in Gram-negative bacteria. By inhibiting LpxH, this compound effectively disrupts the bacterial cell wall synthesis, leading to the weakening and eventual death of the bacteria. Its application is particularly significant in the development of novel antibiotics to combat drug-resistant bacterial strains. Researchers are exploring its potential in treating infections caused by pathogens such as Escherichia coli and Pseudomonas aeruginosa, which are known for their resilience to conventional antibiotics. Additionally, LpxH-IN-AZ1 serves as a valuable tool in biochemical studies to further understand the mechanisms of bacterial resistance and to identify new therapeutic targets.